Lebwohl M, Deodhar A, Griffiths CEM, Menter MA, et al. The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and
ankylosing spondylitis patients: analysis of up to five-year clinical trial and
post-marketing surveillance data. Br J Dermatol 2021 Apr 8. doi: 10.1111/bjd.20136.
PMID: 33829482